Denali Therapeutics Inc. current ratio

The Current Ratio as of November 2026 (TTM) for Denali Therapeutics Inc. (DNLI) is 6.21

According to Denali Therapeutics Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.21. This represents a change of -24.76% compared to the average of 8.26 of the last 4 quarters.

Denali Therapeutics Inc. (DNLI) Historical Current Ratio (quarterly & annually)

How has DNLI Current Ratio performed in the past?

The mean historical Current Ratio of Denali Therapeutics Inc. over the last ten years is 13.13. The current 6.21 Current Ratio has changed -52.70% with respect to the historical average. Over the past ten years (40 quarters), DNLI's Current Ratio was at its highest in in the December 2017 quarter at 28.92. The Current Ratio was at its lowest in in the March 2017 quarter at 0.

Denali Therapeutics Inc. (DNLI) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Denali Therapeutics Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Denali Therapeutics Inc. (DNLI) Average Current Ratio

How has DNLI Current Ratio performed in the past?

The current Current Ratio of Denali Therapeutics Inc. (DNLI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Denali Therapeutics Inc. (DNLI) Current Ratio vs. Peers

How is DNLI’s Current Ratio compared to its peers?

Denali Therapeutics Inc.’s Current Ratio is less than Cognition Therapeutics, Inc. (7.03), less than Ionis Pharmaceuticals, Inc. (7.88), less than Amylyx Pharmaceuticals, Inc. (12.12), greater than Neumora Therapeutics, Inc. Common Stock (4.50), less than ProMIS Neurosciences, Inc. (7.85), less than Rapport Therapeutics, Inc. Common Stock (20.07), greater than Alector, Inc. (5.26), less than Praxis Precision Medicines, Inc. (15.73), greater than Neurocrine Biosciences, Inc. (2.04), greater than Biohaven Ltd. (3.05),

Build a custom stock screener for Denali Therapeutics Inc. (DNLI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Denali Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Denali Therapeutics Inc. (DNLI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Denali Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.